Bank of America’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-115,252
| Closed | -$10.7M | – | 9109 |
|
|
2021
Q4 | $10.7M | Buy |
115,252
+29,653
| +35% | +$1.95M | ﹤0.01% | 2862 |
|
|
2021
Q3 | $5.1M | Buy |
85,599
+9,195
| +12% | +$543K | ﹤0.01% | 3543 |
|
|
2021
Q2 | $5.21M | Sell |
76,404
-12,378
| -14% | -$807K | ﹤0.01% | 3474 |
|
|
2021
Q1 | $6.16M | Buy |
88,782
+22,725
| +34% | +$1.75M | ﹤0.01% | 3196 |
|
|
2020
Q4 | $5.07M | Sell |
66,057
-20,567
| -24% | -$1.54M | ﹤0.01% | 3115 |
|
|
2020
Q3 | $6.48M | Buy |
86,624
+768
| +0.9% | +$51.2K | ﹤0.01% | 2670 |
|
|
2020
Q2 | $5.41M | Buy |
85,856
+11,664
| +16% | +$642K | ﹤0.01% | 2762 |
|
|
2020
Q1 | $3.12M | Sell |
74,192
-135,819
| -65% | -$6.23M | ﹤0.01% | 3124 |
|
|
2019
Q4 | $9.54M | Buy |
210,011
+107,158
| +104% | +$5.07M | ﹤0.01% | 2594 |
|
|
2019
Q3 | $4.71M | Sell |
102,853
-86,925
| -46% | -$4.89M | ﹤0.01% | 3276 |
|
|
2019
Q2 | $11.1M | Buy |
189,778
+43,663
| +30% | +$2.26M | ﹤0.01% | 2440 |
|
|
2019
Q1 | $6.55M | Buy |
146,115
+124,759
| +584% | +$5.72M | ﹤0.01% | 2889 |
|
|
2018
Q4 | $832K | Sell |
21,356
-5,331
| -20% | -$209K | ﹤0.01% | 4558 |
|
|
2018
Q3 | $1.23M | Sell |
26,687
-48,764
| -65% | -$1.98M | ﹤0.01% | 4351 |
|
|
2018
Q2 | $3.29M | Buy |
75,451
+56,530
| +299% | +$2.43M | ﹤0.01% | 3554 |
|
|
2018
Q1 | $748K | Buy |
18,921
+7,112
| +60% | +$277K | ﹤0.01% | 4571 |
|
|
2017
Q4 | $401K | Sell |
11,809
-1,085
| -8% | -$30.9K | ﹤0.01% | 5083 |
|
|
2017
Q3 | $329K | Buy |
12,894
+5,406
| +72% | +$124K | ﹤0.01% | 5172 |
|
|
2017
Q2 | $126K | Sell |
7,488
-2,150
| -22% | -$29.5K | ﹤0.01% | 5518 |
|
|
2017
Q1 | $141K | Buy |
9,638
+4,867
| +102% | +$72.1K | ﹤0.01% | 5475 |
|
|
2016
Q4 | $68K | Buy |
4,771
+3,051
| +177% | +$47.3K | ﹤0.01% | 5794 |
|
|
2016
Q3 | $30K | Sell |
1,720
-1,706
| -50% | -$28.3K | ﹤0.01% | 5962 |
|
|
2016
Q2 | $59K | Buy |
3,426
+2,326
| +211% | +$41.6K | ﹤0.01% | 5767 |
|
|
2016
Q1 | $22K | Sell |
1,100
-3,727
| -77% | -$59.7K | ﹤0.01% | 6107 |
|
|
2015
Q4 | $92K | Buy |
4,827
+3,100
| +180% | +$63.2K | ﹤0.01% | 5771 |
|
|
2015
Q3 | $33K | Sell |
1,727
-15,363
| -90% | -$522K | ﹤0.01% | 6130 |
|
|
2015
Q2 | $793K | Buy |
17,090
+15,562
| +1,018% | +$675K | ﹤0.01% | 4310 |
|
|
2015
Q1 | $67K | Sell |
1,528
-6,324
| -81% | -$294K | ﹤0.01% | 5518 |
|
|
2014
Q4 | $273K | Sell |
7,852
-1,782
| -18% | -$72.3K | ﹤0.01% | 5106 |
|
|
2014
Q3 | $403K | Buy |
9,634
+4,724
| +96% | +$211K | ﹤0.01% | 4796 |
|
|
2014
Q2 | $288K | Sell |
4,910
-50,900
| -91% | -$3.21M | ﹤0.01% | 5195 |
|
|
2014
Q1 | $3.52M | Buy |
55,810
+2,779
| +5% | +$184K | ﹤0.01% | 2712 |
|
|
2013
Q4 | $3.1M | Buy |
53,031
+23,540
| +80% | +$1.23M | ﹤0.01% | 2906 |
|
|
2013
Q3 | $1.55M | Sell |
29,491
-40,369
| -58% | -$2.71M | ﹤0.01% | 3519 |
|
|
2013
Q2 | $5.38M | Buy |
+69,860
| New | +$5.7M | ﹤0.01% | 2224 |
|
Bank of America's ARNA Position: Q1 2022 in Review
Bank of America sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 115,252 shares — an estimated $10.7M sold.
Bank of America first reported a position in ARNA in Q2 2013 and held it in 35 quarters. The position peaked at $11.1M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Bank of America reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Bank of America sold 115,252 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $10.7M.
- Bank of America first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 35 quarters.
- Bank of America's Arena Pharmaceuticals Inc position peaked at $11.1M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.